For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220923:nRSW3782Aa&default-theme=true
RNS Number : 3782A CVS Group plc 23 September 2022
23 September 2022
CVS Group plc
("CVS" or the "Company")
PDMR Dealings
CVS, one of the UK's leading providers of integrated veterinary services,
announces that it was notified on 22 September 2022 that Richard Connell,
Non-executive Chairman of the Company and his wife purchased a total of 4,500
ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same
date.
As a result, Mr Connell's total interest in the Company, including his wife's
holdings, is now 169,000 Ordinary Shares, representing 0.24% per cent of the
total voting rights of the Company. The notification below, made in accordance
with the requirements of UK MAR, provides further detail.
Contacts:
CVS Group plc via MHP Communications
Jenny Farrer Company Secretary
Peel Hunt (Nominated Adviser & Broker) +44 (0)20 7418 8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
MHP Communications (Financial PR) +44 (0) 20 3128 8549
Andrew Jaques / Simon Hockridge / Rachel Farrington / Charles Hirst
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Richard Connell via James Hay Pension Trustees Limited
2 Reason for the notification
a) Position/status PDMR (Chairman) / PCA
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name CVS Group plc
b) LEI 213800J41XDQ2NX48O05
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 0.2 pence each
Identification code
GB00B2863827
b) Nature of the transaction On-market purchase
c) Price(s) and volume(s)
Price(s) - pence Volume(s)
16.18 1,000
d) Aggregated information
- Aggregated volume
1,000
- Price
1,618.00
e) Date of the transaction 22 September 2022
f) Place of the transaction London Stock Exchange - AIM (XLON)
d)
Aggregated information
- Aggregated volume
- Price
1,000
1,618.00
e)
Date of the transaction
22 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Richard Connell and Maire Elizabeth Connell
2 Reason for the notification
a) Position/status PDMR (Chairman) / PCA of a Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name CVS Group plc
b) LEI 213800J41XDQ2NX48O05
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 0.2 pence each
Identification code
GB00B2863827
b) Nature of the transaction On-market purchase
c) Price(s) and volume(s)
Price(s) - pence Volume(s)
16.18 3,500
d) Aggregated information
- Aggregated volume
3,500
- Price
1,618.00
e) Date of the transaction 22 September 2022
f) Place of the transaction London Stock Exchange - AIM (XLON)
d)
Aggregated information
- Aggregated volume
- Price
3,500
1,618.00
e)
Date of the transaction
22 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHEANNAAFAAEFA